The Leadership Team at CARsgen Therapeutics is responsible for guiding the company's strategic direction and fostering collaboration across various functions. This team drives innovation in CAR T-cell therapies, oversees regulatory compliance, and manages partnerships to enhance business development. With a focus on operational efficiency and clinical excellence, they ensure that CARsgen effectively addresses the treatment needs of patients with hematologic malignancies and solid tumors.
Chen Baolu
SVP, CMC Operation
Fan Young
SVP, Global Regulatory Affairs
Hsu Leigh James
SVP, Business Development
Jia Jie
VP, Strategic Alliances & Oper...
Li Zonghai
Co-Founder, CEO & CSO
Raffaele Baffa
Chief Medical Officer
Richard John Daly
President, CARsgen Therapeutic...
Wang Huamao
Co-Founder & COO
Wang Wei
VP, Clinical Development
Zhou Guanjun
Vice President, Government Rel...
View all